CENT News Alert Central Garden & Pet Company (CENT) 7.98 12/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Central Garden & Pet Company (CENT) 7.98 $CENT

Central Garden & Pet's Q4 Loss Narrower than Expected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 10:30AM CST
Central Garden & Pet Co. (CENT) recorded adjusted loss per share of 12 cents in fourth-quarter fiscal 2014, significantly narrower than the Zacks Consensus Estimate of a loss of 25 cents.
PBH: 32.67 (-0.63), CENT: 7.98 (+0.25), NTRI: 18.81 (-0.33), SUMR: 2.76 (+0.01)

Central Garden & Pet beats by $0.13, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 3:37PM CST

CENT: 7.98 (+0.25)

Central Garden reports 4Q loss
Automated Insights - Wed Dec 10, 3:27PM CST
WALNUT CREEK, Calif. (AP) _ Central Garden & Pet Co. (CENT) on Wednesday reported a loss of $4.1 million in its fiscal fourth quarter.
CENT: 7.98 (+0.25), CENTA: 8.52 (+0.05)

Central Garden & Pet Company Announces Fourth Quarter & Fiscal 2014 Results
Business Wire - Wed Dec 10, 3:05PM CST
--Fourth quarter diluted loss per share of ($0.08) per share vs. ($0.47) per share in prior year quarter
CENT: 7.98 (+0.25), CENTA: 8.52 (+0.05)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 4:35PM CST

SIGM: 4.88 (+0.09), RH: 95.09 (+0.09), MW: 42.52 (+1.75), IRET: 8.27 (+0.08), CENT: 7.98 (+0.25), AVNW: 1.38 (+0.02), WTSL: 0.05 (-0.02), PPHM: 1.36 (unch), CASY: 84.45 (-1.54), SURG: 3.87 (+0.04)

Central Garden & Pet Company to Announce Fourth Quarter and Fiscal Year 2014 Financial Results
Business Wire - Mon Dec 08, 5:42PM CST
Central Garden & Pet Company (NASDAQ:CENT)(NASDAQ:CENTA), a leading innovator, marketer and producer of quality branded products for the lawn & garden and pet supplies markets, will announce results for its fourth quarter and fiscal year ended September 27, 2014 on Wednesday, December 10, 2014 after the close of trading. The Company will not be hosting a conference call.
CENT: 7.98 (+0.25), CENTA: 8.52 (+0.05)

Will Central Garden & Pet (CENT) Miss this Q4 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 8:20AM CST
Central Garden & Pet Company (CENT) is expected to report fourth-quarter fiscal 2014 results on Dec 9.
AZO: 597.93 (-7.91), CENT: 7.98 (+0.25), NKE: 93.21 (-2.22), COST: 137.31 (-0.88)

Will Caesars Entertainment's (CZR) Q3 Earnings Disappoint? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:01PM CST
Caesars Entertainment Corporation (CZR) is slated to report its third-quarter 2014 results on Nov 10, 2014.
ISLE: 7.78 (+0.19), CENT: 7.98 (+0.25), BYD: 10.75 (-0.47), CZR: 12.16 (-0.13)

Will Monster Beverage (MNST) Miss Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:00PM CST
Monster Beverage Corporation (MNST) is set to release its third-quarter 2014 results on Nov 6, after the market closes.
KOF: 84.22 (-0.73), MNST: 106.24 (+1.23), CENT: 7.98 (+0.25), TPX: 52.52 (-0.83)

Will Mondelez (MDLZ) Disappoint Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 1:30PM CST
Mondelez International, Inc. (MDLZ) is set to report the third-quarter 2014 results on Nov 5. Last quarter, the company delivered a positive earnings surprise of 2.56%.
MDLZ: 36.02 (-0.65), CENT: 7.98 (+0.25), KRFT: 58.83 (+0.13), SJM: 98.31 (+0.02)

Will SodaStream (SODA) Miss Q3 Earnings on Low Demand? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:50PM CDT
SodaStream International Ltd. (SODA) is set to report third-quarter 2014 results on Oct 29, before market opens.
POST: 40.52 (+0.27), CENT: 7.98 (+0.25), HSY: 97.94 (-0.59), WMT: 82.96 (-0.98), SODA: 20.40 (-0.02)

Shares of CENT Down 11.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 23, 9:55AM CDT
SmarTrend identified a Downtrend for Central Garden and Pet (NASDAQ:CENT) on September 15th, 2014 at $8.26. In approximately 1 month, Central Garden and Pet has returned 11.08% as of today's recent price of $7.34.
CENT: 7.98 (+0.25)

Harbinger Group Inc. Urges Board of Central Garden & Pet to Fulfill its Fiduciary Duties to Shareholders, Calls Upon Shareholders to Voice Opinions Regarding Proposed Transactions
PR Newswire - Mon Oct 20, 6:30AM CDT
Harbinger Group Inc. ("HRG"; NYSE: HRG), a diversified holding company seeking to acquire and grow attractive businesses that can, in the long term, generate sustainable free cash flow, today released a letter to the Board of Directors ("CENT Board" of Central Garden & Pet Company ("CENT" expressing disappointment with the CENT Board announcement rejecting HRG's proposal to acquire all of CENT for $10.00 in cash per share or alternatively to acquire CENT's Pet Segment for $750 million in cash.
CENT: 7.98 (+0.25), CENTA: 8.52 (+0.05), HRG: 13.01 (+0.16)

Central Garden & Pet (CENT) Rejects Harbinger's Proposals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 5:39PM CDT
Central Garden & Pet Company's (CENT) board of directors unanimously rejected the acquisition offer from Harbinger Group Inc.
PBH: 32.67 (-0.63), CENT: 7.98 (+0.25), JAH: 45.63 (+0.10), SPB: 93.93 (+0.50)

Nasdaq stocks posting largest percentage decreases
AP - Wed Oct 15, 5:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
IMDZ: 22.15 (+0.35), CENT: 7.98 (+0.25), AXDX: 17.29 (+0.01), KTCC: 8.00 (-0.01), CENTA: 8.52 (+0.05), EXAC: 22.00 (-0.03), LAKE: 9.19 (-0.46), MTEX: 29.26 (-0.14), IKNX: 15.43 (-0.12)

Central Garden & Pet Will Not Pursue Harbinger Group Proposals
Business Wire - Tue Oct 14, 5:01PM CDT
Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading innovator, marketer and producer of quality branded products for the lawn and garden and pet supplies markets, said today that, after an extensive review, its Board of Directors unanimously concluded that it will not pursue two proposals received from Harbinger Group Inc. in June to acquire all of Central's common stock at $10 per share in cash or, alternatively, to acquire the Company's Pet segment for $750 million in cash. The Board was assisted in its review by Lazard as financial advisor and Cravath, Swaine & Moore LLP as legal advisor.
CENT: 7.98 (+0.25), CENTA: 8.52 (+0.05), HRG: 13.01 (+0.16)

12.3% Return Seen to Date on SmarTrend Central Garden and Pet Call (CENT)
Comtex SmarTrend(R) - Wed Oct 08, 10:06AM CDT
SmarTrend identified a Downtrend for Central Garden and Pet (NASDAQ:CENT) on September 15th, 2014 at $8.26. In approximately 3 weeks, Central Garden and Pet has returned 12.30% as of today's recent price of $7.24.
CENT: 7.98 (+0.25)

Cannabis Therapy Corp Extends Strategic Plan Into Cannabinoid Products for Animal Health
ACCESSWIRE - Thu Aug 14, 11:48AM CDT
Whitefish, MT / August 14, 2014 / From spending on cardiology to oncology to specialty foods, people love their pets and religiously earmark income for requisite and discretionary spending on their furry friends. This is evident through industry expert American Pet Products stating overall expenditures in the pet industry climbed from $43.2 billion in 2008 to $55.72 billion in 2013. Not even the 2009-2013 Great Recession caused consumers to hit the brakes hard on allocating cash for their pets. The largest chunk of the overall spending went to food ($22.6 billion), followed by the veterinary care category ($15.3 billion) and then supplies/Over-the-Counter medicine ($13.7 billion). As noted by Embrace Pet Insurance, the supplies/OTC meds category remains robust, with their analysts estimating that growth in this sector outpaced the 6.7% expansion forecast by American Pet Products in 2013.
CENT: 7.98 (+0.25), MWIV: 166.30 (+1.80), CENTA: 8.52 (+0.05), WOOF: 46.60 (-0.60)

Central Garden Q3 Earnings Miss on Weak Segmental Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 9:39AM CDT
Persistent weakness in both the Pet and Garden segments dragged down Central Garden & Pet Company (CENT) third quarter fiscal 2014 results.
PBH: 32.67 (-0.63), CENT: 7.98 (+0.25), NTRI: 18.81 (-0.33), SUMR: 2.76 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 92

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 155

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 178

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 205

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 76

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 239

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Vivid Seats Simplifies Market Structure and Tax Obligations

Updated Category News Views 221

Vivid Seats Streamlines Corporate Structure Vivid Seats Inc. (NASDAQ: SEAT), a leading online ticket marketplace, has embarked on a transformative journey to simplify its organizational framework. In a strategic move, the company has announced its Corporate Simplification Agreement, aimed at redefining how it operates while enhancing its tax efficiency and overall...

Continue Reading
NLS Pharmaceuticals Soars After Major Merger Announcement

Updated Category News Views 330

NLS Pharmaceuticals Sees Positive Stock Movement NLS Pharmaceuticals Ltd. (NASDAQ: NLSP) is experiencing significant upward momentum in its stock prices following a crucial announcement regarding a proposed merger. The company has filed a Form F-4 registration statement with the Securities and Exchange Commission, signaling an essential step toward completing this merger....

Continue Reading
Orchestra BioMed Achieves Key Financial and Operational Progress

Updated Category News Views 84

Orchestra BioMed Reports on Financial Performance and Business Updates Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO), a pioneering biomedical innovation company, recently presented its robust financial results for Q3 2024, reflecting both significant fiscal health and promising advancements in medical technology. The company is focused on elevating patient care through...

Continue Reading
Nutex Health Inc. Investors Urged to Join Securities Class Action

Updated Category News Views 130

Investors of Nutex Health Inc. Face Opportunities Amid Allegations Investors holding shares in Nutex Health Inc. are currently presented with a remarkable opportunity in light of claims surrounding securities fraud involving the Company. Founded as a notable player in the healthcare sector, Nutex Health has recently come under scrutiny due to alleged misleading statements...

Continue Reading
Empowering Resilience in Education: Embracing Failure with LetMeFail

Updated Category News Views 182

Transforming Education: LetMeFail's Innovative Approach LetMeFail is an exciting new educational initiative aimed at transforming how students perceive and deal with failure. In today's culture, where perfection is often idolized, this program makes it clear that setbacks can serve as important stepping stones toward personal growth and resilience. Unpacking the Goals of...

Continue Reading